Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: A secondary analysis of a randomized, double-blind, placebo-controlled trial

Brooks D. Cash, Mark Pimentel, Satish Sanku Chander Rao, Leonard Weinstock, Lin Chang, Zeev Heimanson, Anthony Lembo

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: A secondary analysis of a randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences